Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A new clinical application of MR spectroscopy in hepatic encephalopathy

A new clinical application of MR spectroscopy in hepatic encephalopathy terminology might be as futile as Sisyphus’ eternal attempt to roll a boulder up a hill only to see it tumble down again. In the case of CCFs, perhaps with next month’s Journal. References 1. Komiyama M, Nishikawa M, Kan M, Shigemoto T, Kaji A. Endovascular treatment of intractable oro-nasal bleeding associated with severe craniofacial injury. J Trauma 1998;44:330 –334 2. Hirai T, Korogi Y, Hamatake S, et al. Three-dimensional FISP imaging in the evaluation of carotid cavernous fistula: comparison with contrast-enhanced CT and spin-echo MR. AJNR Am J Neuroradiol 1998;19:253–259 3. Cornelius R. CCF: imaging evaluation. In: Tomsick TA, ed. Carotid Cavernous Fistula. Cincinnati, OH: Digital Education Publishing; 1997:23–31 4. Parkinson D. Anatomy of the lateral sellar compartments (cavernous sinus). In: Scjodel JJ, Sweet WB, eds. Operative Surgical Techniques. Philadelphia: Saunders; 1995:479 – 492 THOMAS A. TOMSICK Member, Editorial Board University Hospital Cincinnati, OH One of the first disease processes shown to have an abnormal proton MR spectrum was hepatic encephalopathy (HE), in a study in which Ross et al found decreased myo-inositol (mI) (1). Subsequent studies of HE further documented the changes in mI as well as increases in glutamine/glutamate (Glx) and decreases in choline (Cho). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Neuroradiology American Journal of Neuroradiology

A new clinical application of MR spectroscopy in hepatic encephalopathy

Loading next page...
 
/lp/american-journal-of-neuroradiology/a-new-clinical-application-of-mr-spectroscopy-in-hepatic-eXcBCrhd3h

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Journal of Neuroradiology
Copyright
Copyright © 1998 by the American Society of Neuroradiology.
ISSN
0195-6108
eISSN
1936-959X
Publisher site
See Article on Publisher Site

Abstract

terminology might be as futile as Sisyphus’ eternal attempt to roll a boulder up a hill only to see it tumble down again. In the case of CCFs, perhaps with next month’s Journal. References 1. Komiyama M, Nishikawa M, Kan M, Shigemoto T, Kaji A. Endovascular treatment of intractable oro-nasal bleeding associated with severe craniofacial injury. J Trauma 1998;44:330 –334 2. Hirai T, Korogi Y, Hamatake S, et al. Three-dimensional FISP imaging in the evaluation of carotid cavernous fistula: comparison with contrast-enhanced CT and spin-echo MR. AJNR Am J Neuroradiol 1998;19:253–259 3. Cornelius R. CCF: imaging evaluation. In: Tomsick TA, ed. Carotid Cavernous Fistula. Cincinnati, OH: Digital Education Publishing; 1997:23–31 4. Parkinson D. Anatomy of the lateral sellar compartments (cavernous sinus). In: Scjodel JJ, Sweet WB, eds. Operative Surgical Techniques. Philadelphia: Saunders; 1995:479 – 492 THOMAS A. TOMSICK Member, Editorial Board University Hospital Cincinnati, OH One of the first disease processes shown to have an abnormal proton MR spectrum was hepatic encephalopathy (HE), in a study in which Ross et al found decreased myo-inositol (mI) (1). Subsequent studies of HE further documented the changes in mI as well as increases in glutamine/glutamate (Glx) and decreases in choline (Cho).

Journal

American Journal of NeuroradiologyAmerican Journal of Neuroradiology

Published: Jan 1, 1998

There are no references for this article.